← 返回

A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation.

A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation.

期刊: Medicine 日期: 2026-06-19 PMID: 42332466 DOI: 10.1097/MD.0000000000049341 浏览: 22
作者: Zhang Z, Li D, Zhao J, Ma H, Wang F, Hao Q
Z, Z., D, L., J, Z., H, M., F, W., & Q, H. (2026). A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation.. Medicine. https://doi.org/10.1097/MD.0000000000049341
Z Z, D L, J Z, H M, F W, Q H. A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation.. Medicine. 2026; doi: 10.1097/MD.0000000000049341
Z Z, D L, J Z, et al. A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation.[J]. Medicine. 2026. DOI: 10.1097/MD.0000000000049341.
@article{z2026,
  author = {Zhang Z and Li D and Zhao J and Ma H and Wang F and Hao Q},
  title = {A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation.},
  journal = {Medicine},
  year = {2026},
  doi = {10.1097/MD.0000000000049341},
  note = {PMID: 42332466},
}
TY  - JOUR
AU  - Zhang Z
AU  - Li D
AU  - Zhao J
AU  - Ma H
AU  - Wang F
AU  - Hao Q
TI  - A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation.
T2  - Medicine
PY  - 2026
DO  - 10.1097/MD.0000000000049341
AN  - PMID:42332466
ER  - 

摘要

Heart failure (HF) commonly coexists with type 2 diabetes mellitus (T2DM), and this combination is linked to a heavier symptom burden and less favorable clinical outcomes. In this retrospective single-center study, a total of 958 consecutive patients were included, among whom 453 had T2DM, with a mean age of 68.23 ± 5.76 years. The diagnosis of HF was confirmed by a multidisciplinary team in accordance with the European Society of Cardiology criteria, and 232 patients were found to have both T2DM and HF. Relative to diabetic patients without HF, those with HF more often presented with dyspnea or fatigue, paroxysmal nocturnal dyspnea/orthopnea, and ankle swelling or nocturia (all P < .001). They also showed higher rates of wheezing/rhonchi (P = .021), fluid and sodium retention (P = .008), ST-T abnormalities (P = .033), abnormal Q-waves (P = .001), and NT-proBNP levels ≥ 15 pmol/L (approximately 125 pg/mL; P < .001). Potential predictors were first selected using least absolute shrinkage and selection operator (LASSO) regression, after which multivariable logistic regression was performed to construct a nomogram for predicting HF risk in patients with T2DM. The multivariable model indicated that ST-T abnormalities, NT-proBNP, ischemic heart disease, and atrial fibrillation were independently related to HF (all P < .05). The nomogram exhibited strong apparent discriminatory ability together with satisfactory calibration, suggesting that NT-proBNP-based risk stratification may be useful for HF screening in individuals with T2DM.

AI 智能解读

相关文献

返回分类: 心衰 查看原文 (DOI)
已选择 0 篇文献